|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.470 USD | +0.27% |
|
+1.91% | -15.31% |
Evolution of the Average Target: Vanda Pharmaceuticals Inc.
Evolution of the Target Price: Vanda Pharmaceuticals Inc.
Changes in Analyst Recommendations: Vanda Pharmaceuticals Inc.
ec8509243f0186672a15611226ba.W0l38x-pScXHPExwkDctXPZdRtEYhq_HEnWT3GoqOlA.AwQB3izvJY-IbA814gBhO6k7J-lV8ZqsfE3Hjx0SUj0aLj2BLt0h8YFzDQ~2ffe898de3074d8bfe2a5ad277151dbd
More recommendations
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +82.4% | |||||
| +18.83% | |||||
| +24.54% | |||||
| +32.54% | |||||
| +26.81% | |||||
| +2.93% | |||||
| -1.58% | |||||
| +42.51% | |||||
| +12.44% | |||||
| +90.29% | |||||
| Average | +33.17% | |||||
| Weighted average by Cap. | +24.66% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
7.470USD
Average target price
13.62USD
Spread / Average Target
+82.40%
High Price Target
22.00USD
Spread / Highest target
+194.51%
Low Price Target
7.500USD
Spread / Lowest Target
+0.40%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| B. Riley | |
| HC Wainwright | |
| Jefferies & Co. | |
| BofA Securities | |
| Citigroup |
SellBuy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
7.470USD
Average target price
13.62USD
Spread / Average Target
+82.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VNDA Stock
- Consensus Vanda Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition